EyePoint (EYPT) Operating Leases (2019 - 2026)
EyePoint (EYPT) reported Operating Leases of $20.2 million for Q1 2026, down 9.34% on a YoY basis from $22.3 million in Q1 2025, and down 2.61% sequentially from $20.8 million in Q4 2025.
EyePoint (EYPT) Operating Leases (2019 - 2026) Analysis & Trends
EyePoint (EYPT) has 8 years of Operating Leases data on file, last reported at $20.2 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 9.34% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (down 9.34% YoY), and the FY2025 full-year result was $20.8 million, down 4.97% from the prior year.
- Operating Leases slipped to $20.2 million in Q1 2026, from $20.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $22.3 million in Q1 2025 to a low of $1.7 million in Q1 2022.
- A 5-year average of $12.7 million and a median of $6.2 million in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases decreased 21.87% in 2022 and soared 382.57% in 2025, its largest moves.
- Tracing EYPT's Operating Leases over 5 years: stood at $6.0 million in 2022, then slipped by 18.01% to $4.9 million in 2023, then jumped by 345.54% to $21.9 million in 2024, then slipped by 4.97% to $20.8 million in 2025, then declined by 2.61% to $20.2 million in 2026.
- Business Quant data shows EYPT's Operating Leases at $20.2 million in Q1 2026, $20.8 million in Q4 2025, and $21.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.23 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Sep 30, 2025 | 21.30 Mn |
| Jun 30, 2025 | 21.82 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Dec 31, 2024 | 21.86 Mn |
| Sep 30, 2024 | 21.92 Mn |
| Jun 30, 2024 | 22.16 Mn |
| Mar 31, 2024 | 4.62 Mn |
| Dec 31, 2023 | 4.91 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.46 Mn |
| Mar 31, 2023 | 5.72 Mn |
| Dec 31, 2022 | 5.98 Mn |
| Sep 30, 2022 | 6.24 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 2.02 Mn |
| Jun 30, 2021 | 2.01 Mn |